Literature DB >> 16044404

Preparation and characterization of nano-hydroxyapatite/chitosan composite scaffolds.

Lijun Kong1, Yuan Gao, Wenling Cao, Yandao Gong, Nanming Zhao, Xiufang Zhang.   

Abstract

A novel nano-hydroxyapatite (HA)/chitosan composite scaffold with high porosity was developed. The nano-HA particles were made in situ through a chemical method and dispersed well on the porous scaffold. They bound to the chitosan scaffolds very well. This method prevents the migration of nano-HA particles into surrounding tissues to a certain extent. The morphologies, components, and biocompatibility of the composite scaffolds were investigated. Scanning electron microscopy, porosity measurement, thermogravimetric analysis, X-ray diffraction, X-ray photoelectron spectroscopy, and Fourier transformed infrared spectroscopy were used to analyze the physical and chemical properties of the composite scaffolds. The biocompatibility was assessed by examining the proliferation and morphology of MC 3T3-E1 cells seeded on the scaffolds. The composite scaffolds showed better biocompatibility than pure chitosan scaffolds. The results suggest that the newly developed nano-HA/chitosan composite scaffolds may serve as a good three-dimensional substrate for cell attachment and migration in bone tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16044404     DOI: 10.1002/jbm.a.30414

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  30 in total

1.  Development of porous HAp and β-TCP scaffolds by starch consolidation with foaming method and drug-chitosan bilayered scaffold based drug delivery system.

Authors:  B Kundu; A Lemos; C Soundrapandian; P S Sen; S Datta; J M F Ferreira; D Basu
Journal:  J Mater Sci Mater Med       Date:  2010-07-20       Impact factor: 3.896

2.  Historic and current strategies in bone tissue engineering: do we have a hope in Hench?

Authors:  Eileen Gentleman; Julia M Polak
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

3.  A comparison of different nanostructured biomaterials in subcutaneous tissue.

Authors:  Julia C Vogt; Gudrun Brandes; Ilka Krüger; Peter Behrens; Ingo Nolte; Thomas Lenarz; Martin Stieve
Journal:  J Mater Sci Mater Med       Date:  2008-01-16       Impact factor: 3.896

Review 4.  Biocomposites and hybrid biomaterials based on calcium orthophosphates.

Authors:  Sergey V Dorozhkin
Journal:  Biomatter       Date:  2011 Jul-Sep

5.  Towards high throughput tissue engineering: development of chitosan-calcium phosphate scaffolds for engineering bone tissue from embryonic stem cells.

Authors:  Junghyuk Ko; Kathleen Kolehmainen; Farid Ahmed; Martin Bg Jun; Stephanie M Willerth
Journal:  Am J Stem Cells       Date:  2011-10-20

6.  Heparinized hydroxyapatite/collagen three-dimensional scaffolds for tissue engineering.

Authors:  S Teixeira; L Yang; P J Dijkstra; M P Ferraz; F J Monteiro
Journal:  J Mater Sci Mater Med       Date:  2010-07-02       Impact factor: 3.896

7.  Adipose-derived stem cells and BMP-2 delivery in chitosan-based 3D constructs to enhance bone regeneration in a rat mandibular defect model.

Authors:  Jiabing Fan; Hyejin Park; Matthew K Lee; Olga Bezouglaia; Armita Fartash; Jinku Kim; Tara Aghaloo; Min Lee
Journal:  Tissue Eng Part A       Date:  2014-05-09       Impact factor: 3.845

8.  Preparation and biological properties of a novel composite scaffold of nano-hydroxyapatite/chitosan/carboxymethyl cellulose for bone tissue engineering.

Authors:  Jiang Liuyun; Li Yubao; Xiong Chengdong
Journal:  J Biomed Sci       Date:  2009-07-14       Impact factor: 8.410

9.  Chitosan-based scaffolds for bone tissue engineering.

Authors:  Sheeny Lan Levengood; Miqin Zhang
Journal:  J Mater Chem B       Date:  2014-06-07       Impact factor: 6.331

10.  Preparation and properties of a novel bone repair composite: nano-hydroxyapatite/chitosan/carboxymethyl cellulose.

Authors:  Jiang Liuyun; Li Yubao; Zhang Li; Liao Jianguo
Journal:  J Mater Sci Mater Med       Date:  2007-07-31       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.